Learn More
Medchemexpress LLC JH-XVI-178 | 2648453-53-4 | MFCD09701325 | 98.9% | 435.91 g/mol | C22H22ClN7O | 5 MG

Supplier: Medchemexpress LLC HY1398755MG
A potent, selective small-molecule inhibitor of cyclin-dependent kinases CDK8 and CDK19 for research use. The compound displays low clearance and moderate oral pharmacokinetic properties and is supplied as a high-purity research powder with recommended storage and solubility guidance.
- Potent, selective CDK8 and CDK19 inhibition with low-nanomolar IC50s (1 nM and 2 nM).
- High purity (≈98.9%) suitable for research applications.
- Supplied as a small research-scale powder (5 mg).
- Soluble in DMSO at 62.5 mg/mL; sonication recommended.
- Stable when stored as powder at -20°C for long-term storage.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.